{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:44:54Z","timestamp":1792197894244,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11596-022-2607-3","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T15:03:35Z","timestamp":1658588615000},"page":"673-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review"],"prefix":"10.1007","volume":"42","author":[{"given":"Meng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"issue":"1","key":"2607_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1756283X09352095","volume":"3","author":"SH Pang","year":"2010","unstructured":"Pang SH, Graham DY. A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers. Therap Adv Gastroenterol, 2010,3(1):11\u201322","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"2607_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MED.0000000000000031","volume":"21","author":"VD Corleto","year":"2014","unstructured":"Corleto VD, Festa S, Di Giulio E, et al. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes, 2014,21(1):3\u20138","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2607_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ncp.10181","volume":"33","author":"A Singh","year":"2018","unstructured":"Singh A, Cresci GA, Kirby DF. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutr Clin Pract, 2018,33(5):614\u2013624","journal-title":"Nutr Clin Pract"},{"issue":"4","key":"2607_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.dld.2015.12.009","volume":"48","author":"T Yu","year":"2016","unstructured":"Yu T, Tang Y, Jiang L, et al. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis. Dig Liver Dis, 2016,48(4):353\u2013359","journal-title":"Dig Liver Dis"},{"issue":"11","key":"2607_CR5","doi-asserted-by":"publisher","first-page":"e110503","DOI":"10.1371\/journal.pone.0110503","volume":"9","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Bota S, Schwabl P, et al. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PLoS One, 2014,9(11):e110503","journal-title":"PLoS One"},{"issue":"6","key":"2607_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1742-1241.2011.02650.x","volume":"65","author":"G Trikudanathan","year":"2011","unstructured":"Trikudanathan G, Israel J, Cappa J, et al. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients \u2014 a systematic review and meta-analysis. Int J Clin Pract, 2011,65(6):674\u2013678","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2607_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/apt.12875","volume":"40","author":"YW Min","year":"2014","unstructured":"Min YW, Lim KS, Min BH, et al. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Aliment Pharmacol Ther, 2014,40(6):695\u2013704","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2607_CR8","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.4238\/2015.July.3.25","volume":"14","author":"HB Xu","year":"2015","unstructured":"Xu HB, Wang HD, Li CH, et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis. Genet Mol Res, 2015,14(3):7490\u20137501","journal-title":"Genet Mol Res"},{"issue":"11","key":"2607_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/apt.13172","volume":"41","author":"JB Dever","year":"2015","unstructured":"Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis\u2014bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther, 2015,41(11):1116\u20131131","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2607_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology, 2013,57(4):1651\u20131653","journal-title":"Hepatology"},{"issue":"9","key":"2607_CR11","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1111\/liv.12795","volume":"35","author":"P Schwabl","year":"2015","unstructured":"Schwabl P, Bucsics T, Soucek K, et al. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. Liver Int, 2015,35(9):2121\u20132128","journal-title":"Liver Int"},{"issue":"5","key":"2607_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3109\/00365521.2011.551891","volume":"46","author":"EJ Choi","year":"2011","unstructured":"Choi EJ, Lee HJ, Kim KO, et al. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Scand J Gastroenterol, 2011,46(5):616\u2013620","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2607_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ajg.2009.80","volume":"104","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Zadvornova Y, Heuman DM, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol, 2009,104(5):1130\u20131134","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2607_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","volume":"62","author":"R Terg","year":"2015","unstructured":"Terg R, Casciato P, Garbe C, et al. Study Group of Cirrhosis Complications of the Argentine Association for the Study of Liver Disease. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol, 2015,62(5):1056\u20131060","journal-title":"J Hepatol"},{"issue":"4","key":"2607_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep.28737","volume":"64","author":"G Dam","year":"2016","unstructured":"Dam G, Vilstrup H, Watson H, et al. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology, 2016,64(4):1265\u20131272","journal-title":"Hepatology"},{"issue":"2","key":"2607_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12072-019-09932-9","volume":"13","author":"K Yamamoto","year":"2019","unstructured":"Yamamoto K, Ishigami M, Honda T, et al. Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Hepatol Int, 2019,13(2):234\u2013244","journal-title":"Hepatol Int"},{"issue":"4","key":"2607_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10620-017-4905-3","volume":"63","author":"E Yasutomi","year":"2018","unstructured":"Yasutomi E, Hoshi N, Adachi S, et al. Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria. Dig Dis Sci, 2018,63(4):881\u2013889","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2607_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/liv.12593","volume":"35","author":"M Merli","year":"2015","unstructured":"Merli M, Lucidi C, Di Gregorio V, et al. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int, 2015,35(2):362\u2013369","journal-title":"Liver Int"},{"issue":"9","key":"2607_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/apt.12045","volume":"36","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Ratliff SM, Heuman DM, et al. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther, 2012,36(9):866\u2013874","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"2607_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2169\/internalmedicine.53.2021","volume":"53","author":"K Miura","year":"2014","unstructured":"Miura K, Tanaka A, Yamamoto T, et al. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis. Intern Med, 2014,53(10):1037\u20131042","journal-title":"Intern Med"},{"key":"2607_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejim.2016.04.016","volume":"32","author":"KW Huang","year":"2016","unstructured":"Huang KW, Kuan YC, Luo JC, et al. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis. Eur J Intern Med, 2016,32:91\u201395","journal-title":"Eur J Intern Med"},{"issue":"6","key":"2607_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1155\/2014\/751921","volume":"28","author":"M Ratelle","year":"2014","unstructured":"Ratelle M, Perreault S, Villeneuve JP, et al. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Can J Gastroenterol Hepatol, 2014,28(6):330\u2013334","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"2607_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cgh.2011.11.019","volume":"10","author":"GA Goel","year":"2012","unstructured":"Goel GA, Deshpande A, Lopez R, et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol, 2012,10(4):422\u2013427","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2607_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1590\/s0004-2803.201800000-09","volume":"55","author":"IB L\u00e1zaro-Pacheco","year":"2018","unstructured":"L\u00e1zaro-Pacheco IB, Serv\u00edn-Caama\u00f1o AI, P\u00e9rez-Hern\u00e1ndez JL, et al. Proton pump inhibitors increase the overall risk of developing bacterial infections in patients with cirrhosis. Arq Gastroenterol, 2018,55(1):28\u201332","journal-title":"Arq Gastroenterol"},{"issue":"7","key":"2607_CR25","first-page":"407","volume":"21","author":"S Jamil","year":"2011","unstructured":"Jamil S, Ahmed S, Memon A, et al. Factors predicting the recurrence of spontaneous bacterial peritonitis in patients with cirrhosis. J Coll Physicians Surg Pak, 2011,21(7):407\u2013410","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"2607_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000487963","volume":"26","author":"AN Elzouki","year":"2019","unstructured":"Elzouki AN, Neffati N, Rasoul FA, et al. Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. GE Port J Gastroenterol, 2019,26(2):83\u201389","journal-title":"GE Port J Gastroenterol"},{"issue":"2","key":"2607_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s10620-007-9899-9","volume":"53","author":"MS Campbell","year":"2008","unstructured":"Campbell MS, Obstein K, Reddy KR, et al. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci, 2008,53(2):394\u2013398","journal-title":"Dig Dis Sci"},{"issue":"35","key":"2607_CR28","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.4254\/wjh.v9.i35.1278","volume":"9","author":"SAS Miozzo","year":"2017","unstructured":"Miozzo SAS, John JA, Appel-da-Silva MC, et al. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis. World J Hepatol, 2017,9(35):1278\u20131285","journal-title":"World J Hepatol"},{"issue":"4","key":"2607_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jgh.12426","volume":"29","author":"JH Kwon","year":"2014","unstructured":"Kwon JH, Koh SJ, Kim W, et al. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. J Gastroenterol Hepatol, 2014,29(4):775\u2013781","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2607_CR30","first-page":"450","volume":"30","author":"C Triantos","year":"2017","unstructured":"Triantos C, Kalafateli M, Spantidea PI, et al. Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study. Ann Gastroenterol, 2017,30(4):450\u2013456","journal-title":"Ann Gastroenterol"},{"issue":"9","key":"2607_CR31","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/liv.13862","volume":"38","author":"TL Tergast","year":"2018","unstructured":"Tergast TL, Wranke A, Laser H, et al. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis. Liver Int, 2018,38(9):1602\u20131613","journal-title":"Liver Int"},{"issue":"22","key":"2607_CR32","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1097\/MD.0000000000000944","volume":"94","author":"SS Chang","year":"2015","unstructured":"Chang SS, Lai CC, Lee MG, et al. Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression. Medicine (Baltimore), 2015,94(22):e944","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2607_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.5604\/01.3001.0012.7193","volume":"17","author":"TH Hung","year":"2018","unstructured":"Hung TH, Tseng CW, Lee HF, et al. Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. Ann Hepatol, 2018,17(6):933\u2013939","journal-title":"Ann Hepatol"},{"issue":"4","key":"2607_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","volume":"13","author":"JG O\u2019Leary","year":"2015","unstructured":"O\u2019Leary JG, Reddy KR, Wong F, et al. North American Consortium for the Study of End-Stage Liver Disease. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol, 2015,13(4):753\u2013759","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2607_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/jgh.13637","volume":"32","author":"JH Kim","year":"2017","unstructured":"Kim JH, Lim KS, Min YW, et al. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis. J Gastroenterol Hepatol, 2017,32(5):1064\u20131070","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"2607_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MEG.0000000000001499","volume":"32","author":"T Janka","year":"2020","unstructured":"Janka T, Tornai T, Borb\u00e9ly B, et al. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. Eur J Gastroenterol Hepatol, 2020,32(2):257\u2013264","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"2607_CR37","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","volume":"113","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Acharya C, Fagan A, et al. Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in Cirrhosis. Am J Gastroenterol, 2018,113(8):1177\u20131186","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2607_CR38","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/liv.12210","volume":"33","author":"M de Vos","year":"2013","unstructured":"de Vos M, De Vroey B, Garcia BG, et al. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liver Int, 2013,33(9):1316\u20131323","journal-title":"Liver Int"},{"key":"2607_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/HMER.S164250","volume":"11","author":"S Marciano","year":"2019","unstructured":"Marciano S, D\u00edaz JM, Dirchwolf M, et al. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med, 2019,11:13\u201322","journal-title":"Hepat Med"},{"issue":"3","key":"2607_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hep.1840160318","volume":"16","author":"J Llach","year":"1992","unstructured":"Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology, 1992,16(3):724\u2013727","journal-title":"Hepatology"},{"issue":"5","key":"2607_CR41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jhep.2011.02.022","volume":"55","author":"HD Nischalke","year":"2011","unstructured":"Nischalke HD, Berger C, Aldenhoff K, et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol, 2011,55(5):1010\u20131016","journal-title":"J Hepatol"},{"issue":"4","key":"2607_CR42","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/hep.23440","volume":"51","author":"B Appenrodt","year":"2010","unstructured":"Appenrodt B, Gr\u00fcnhage F, Gentemann MG, et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology, 2010,51(4):1327\u20131333","journal-title":"Hepatology"},{"issue":"5","key":"2607_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.chom.2015.03.006","volume":"17","author":"V Leone","year":"2015","unstructured":"Leone V, Gibbons SM, Martinez K, et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe, 2015,17(5):681\u2013689","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2607_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/cid\/ciy205","volume":"67","author":"T Inoue","year":"2018","unstructured":"Inoue T, Nakayama J, Moriya K, et al. Gut dysbiosis associated with Hepatitis C virus infection. Clin Infect Dis, 2018,67(6):869\u2013877","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2607_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol, 2013,58(5):949\u2013955","journal-title":"J Hepatol"},{"issue":"10","key":"2607_CR46","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/ajg.2013.221","volume":"108","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Zhai H, Geng J, et al. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing. Am J Gastroenterol, 2013,108(10):1601\u20131611","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"2607_CR47","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/apt.12304","volume":"37","author":"C Jacobs","year":"2013","unstructured":"Jacobs C, Coss Adame E, Attaluri A, et al. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther, 2013,37(11):1103\u20131111","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2607_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","volume":"8","author":"L Lombardo","year":"2010","unstructured":"Lombardo L, Foti M, Ruggia O, et al. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol, 2010,8(6):504\u2013508","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2607_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/hepr.13249","volume":"49","author":"Y Okura","year":"2019","unstructured":"Okura Y, Namisaki T, Sato S, et al. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatol Res, 2019,49(2):232\u2013238","journal-title":"Hepatol Res"},{"issue":"7","key":"2607_CR50","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1365-2362.2011.02643.x","volume":"42","author":"LG van Vlerken","year":"2012","unstructured":"van Vlerken LG, Huisman EJ, van Hoek B, et al. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. Eur J Clin Invest, 2012,42(7):760\u2013767","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"2607_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1046\/j.1365-2036.2000.014s1074.x","volume":"14","author":"N Yoshida","year":"2000","unstructured":"Yoshida N, Yoshikawa T, Tanaka Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors\u2014inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther, 2000,14(Suppl 1):74\u201381","journal-title":"Aliment Pharmacol Ther"},{"issue":"7480","key":"2607_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 2013,504(7480):446\u2013450","journal-title":"Nature"},{"issue":"7","key":"2607_CR53","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s10620-008-0528-z","volume":"54","author":"LJ Murray","year":"2009","unstructured":"Murray LJ, Gabello M, Rudolph DS, et al. Transmucosal gastric leak induced by proton pump inhibitors. Dig Dis Sci, 2009,54(7):1408\u20131417","journal-title":"Dig Dis Sci"},{"issue":"3","key":"2607_CR54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1091\/mbc.11.3.849","volume":"11","author":"Y Chen","year":"2000","unstructured":"Chen Yh, Lu Q, Schneeberger EE, et al. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell, 2000,11(3):849\u2013862","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2607_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1067-1927.2004.012116.x","volume":"12","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Masaoka T, Minegishi Y, et al. Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44\/p42 mitogen-activated protein kinase. Wound Repair Regen, 2004,12(1):93\u201399","journal-title":"Wound Repair Regen"},{"issue":"3","key":"2607_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0169-409X(00)00047-8","volume":"41","author":"H Clarke","year":"2000","unstructured":"Clarke H, Marano CW, Peralta Soler A, et al. Modification of tight junction function by protein kinase C isoforms. Adv Drug Deliv Rev, 2000,41(3):283\u2013301","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2607_CR57","doi-asserted-by":"publisher","first-page":"e0138881","DOI":"10.1371\/journal.pone.0138881","volume":"10","author":"MW Hess","year":"2015","unstructured":"Hess MW, de Baaij JH, Gommers LM, et al. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice. PLoS One, 2015,10(9): e0138881","journal-title":"PLoS One"},{"issue":"9","key":"2607_CR58","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/apt.13788","volume":"44","author":"A Horvath","year":"2016","unstructured":"Horvath A, Leber B, Schmerboeck B, et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther, 2016,44(9):926\u2013935","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2607_CR59","first-page":"767","volume":"116","author":"S Zhang","year":"2003","unstructured":"Zhang S, Wang W, Ren W, et al. Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats. Chin Med J (Engl), 2003,116(5):767\u2013771","journal-title":"Chin Med J (Engl)"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2607-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2607-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2607-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:20:03Z","timestamp":1660411203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2607-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2607"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2607-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"24 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no competing interests in this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}},{"value":"Author Tao CHEN is a member of Youth Editorial Committee for Current Medical Science. The paper was handled by the other editors and has undergone rigorous peer review process. Authors Tao CHEN were not involved in the journal\u2019s review of, or decisions related to, this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}